Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$2.88B |
| 2 |
British American Tobacco
BTI
|
+$746M |
| 3 |
Becton Dickinson
BDX
|
+$691M |
| 4 |
Baker Hughes
BKR
|
+$650M |
| 5 |
CELG
Celgene Corp
CELG
|
+$646M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$2.75B |
| 2 |
Apple
AAPL
|
+$1.81B |
| 3 |
BHI
Baker Hughes
BHI
|
+$1.26B |
| 4 |
Medtronic
MDT
|
+$1.25B |
| 5 |
Charter Communications
CHTR
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.6% |
| 2 | Technology | 16.57% |
| 3 | Healthcare | 14.29% |
| 4 | Communication Services | 11.09% |
| 5 | Consumer Discretionary | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
GATX Corp
GATX
$6.35B
| $8.9M | ﹤0.01% |
144,519
-149,285
| -51% | -$9.19M |
|
1927
StealthGas
GASS
$332M
| $8.9M | ﹤0.01% |
2,687,517
-1,037,040
| -28% | -$3.27M |
|
1928
The RMR Group
RMR
$325M
| $8.88M | ﹤0.01% |
172,988
+110,945
| +179% | +$5.48M |
|
1929
Viavi Solutions
VIAV
$9.12B
| $8.86M | ﹤0.01% |
936,352
-491,265
| -34% | -$5.12M |
|
|
ONDK
1930
DELISTED
On Deck Capital, Inc.
ONDK
| $8.81M | ﹤0.01% |
1,887,758
-400,000
| -17% | -$1.86M |
|
1931
Greenlight Captial
GLRE
$552M
| $8.81M | ﹤0.01% |
406,760
-170,239
| -30% | -$3.67M |
|
|
TTPH
1932
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $8.8M | ﹤0.01% |
64,342
-2,460
| -4% | -$329K |
|
1933
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
| $8.76M | ﹤0.01% |
70,929
-136,260
| -66% | -$16.9M |
|
1934
Preformed Line Products
PLPC
$1.75B
| $8.71M | ﹤0.01% |
129,343
+327
| +0.3% | +$17.2K |
|
1935
The GEO Group
GEO
$4.13B
| $8.7M | ﹤0.01% |
323,400
-306,000
| -49% | -$8.46M |
|
1936
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
| $8.68M | ﹤0.01% |
563,732
| – | – |
|
1937
iShares US Financial Services ETF
IYG
$2.16B
| $8.68M | ﹤0.01% |
217,197
-59,427
| -21% | -$2.28M |
|
1938
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $8.61M | ﹤0.01% |
+80,790
| New | +$8.66M |
|
|
CLSD
1939
DELISTED
Clearside Biomedical
CLSD
| $8.58M | ﹤0.01% |
65,413
-6
| -0% | -$733 |
|
|
RATE
1940
DELISTED
Bankrate Inc
RATE
| $8.56M | ﹤0.01% |
613,781
-1,942,483
| -76% | -$27M |
|
|
PKD
1941
DELISTED
Parker Drilling Company
PKD
| $8.55M | ﹤0.01% |
518,200
+9,467
| +2% | +$173K |
|
1942
Vera Bradley
VRA
$97M
| $8.46M | ﹤0.01% |
960,823
-4,228
| -0.4% | -$39.5K |
|
|
DRNA
1943
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $8.46M | ﹤0.01% |
1,471,111
-878,599
| -37% | -$3.2M |
|
|
CMTA
1944
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $8.45M | ﹤0.01% |
+500,000
| New | +$8.17M |
|
|
MIME
1945
DELISTED
Mimecast Limited
MIME
| $8.42M | ﹤0.01% |
296,200
-1,900
| -0.6% | -$52.3K |
|
1946
Axsome Therapeutics
AXSM
$11.2B
| $8.41M | ﹤0.01% |
1,516,212
-226,800
| -13% | -$1.22M |
|
1947
Orthofix Medical
OFIX
$477M
| $8.35M | ﹤0.01% |
+176,632
| New | +$8.32M |
|
1948
Codexis
CDXS
$151M
| $8.34M | ﹤0.01% |
1,253,722
+22,693
| +2% | +$126K |
|
1949
Novavax
NVAX
$1.2B
| $8.32M | ﹤0.01% |
364,917
-357,465
| -49% | -$8M |
|
|
SIR
1950
DELISTED
SELECT INCOME REIT
SIR
| $8.32M | ﹤0.01% |
808,230
| – | – |
|
Similar funds
Fidelity Investments's Q3 2017 Portfolio in Review
As of Q3 2017, Fidelity Investments held 2,720 positions worth $827B, up 2.8% from $805B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Fidelity Investments's Q3 2017 filing shows 114 new, 1,012 increased, 1,186 reduced and 130 closed positions. Its largest new stake was Baker Hughes: 18,309,847 shares worth $671M. The largest sale was Du Pont De Nemours E I, an estimated $2.75B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Fidelity Investments's largest Q3 2017 buy was Baker Hughes: 18,309,847 shares worth $671M.
- Fidelity Investments added most to DuPont de Nemours in Q3 2017, an estimated $2.88B increase.
- Fidelity Investments's biggest Q3 2017 reduction was Apple, cutting an estimated $1.81B.
- Fidelity Investments fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $2.75B.
- Fidelity Investments's ten largest holdings make up 18% of its $827B portfolio in Q3 2017.
- Fidelity Investments opened 114 new positions and closed 130 in Q3 2017.
- Fidelity Investments's portfolio value rose 2.8% quarter-over-quarter to $827B.
Based on Fidelity Investments's 13F filing for Q3 2017, filed 13 Nov 2017.